Blood transfusion at delivery and risk of subsequent malignant lymphoma in the mother
- PMID: 9784669
Blood transfusion at delivery and risk of subsequent malignant lymphoma in the mother
Abstract
Background and objectives: Blood transfusion has been shown to be a risk factor for non-Hodgkin's lymphoma (NHL).
Materials and methods: In a cohort of 77,928 women with bleeding complications at delivery in the period of 1973-1986, subsequent NHL cases were identified and the number was compared with the number expected from national incidence rates. In a case-control study the proportion of transfused NHL cases was compared with the proportion of transfused controls.
Results: The observed number of NHL in the cohort was 18 versus 22.0 expected. Information on transfusion was obtained for 15 of the NHL cases and none (0%) was transfused versus 32 out of 136 controls (23%).
Conclusions: Blood transfusion at delivery is not a risk factor for NHL. The immune tolerance induced by pregnancy may reduce the risk of NHL associated with the transfusion of allogeneic blood cells.
Similar articles
-
Allogeneic blood transfusion as a risk factor for the subsequent development of non-Hodgkin's lymphoma.Transfus Med Rev. 2000 Jul;14(3):258-68. doi: 10.1053/tm.20000.7395. Transfus Med Rev. 2000. PMID: 10914420 Review.
-
Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women.Am J Epidemiol. 2004 Aug 15;160(4):325-30. doi: 10.1093/aje/kwh233. Am J Epidemiol. 2004. PMID: 15286017
-
Family history of hematopoietic malignancy and risk of lymphoma.J Natl Cancer Inst. 2005 Oct 5;97(19):1466-74. doi: 10.1093/jnci/dji293. J Natl Cancer Inst. 2005. PMID: 16204696
-
Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993.Haematologica. 2001 Jan;86(1):58-63. Haematologica. 2001. PMID: 11146572
-
The epidemiology of non-Hodgkin lymphoma.Pathology. 2005 Dec;37(6):409-19. doi: 10.1080/00313020500370192. Pathology. 2005. PMID: 16373224 Review.
Cited by
-
Wissenschaftliche Erläuterungen zur Stellungnahme Transfusionsassoziierte Immunmodulation (TRIM) des Arbeitskreises Blut vom 13. Februar 2020 : Bei der 88. Sitzung des Arbeitskreises Blut am 13. Februar 2020 wurde folgende Ergänzung zu Stellungnahme (S 22) verabschiedet.Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Aug;63(8):1025-1053. doi: 10.1007/s00103-020-03183-y. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 32719887 Free PMC article. German. No abstract available.
-
Cancer risk among 21st century blood transfusion recipients.Ann Oncol. 2017 Feb 1;28(2):393-399. doi: 10.1093/annonc/mdw555. Ann Oncol. 2017. PMID: 28426101 Free PMC article.
-
Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study.Int J Cancer. 2008 Aug 15;123(4):888-94. doi: 10.1002/ijc.23561. Int J Cancer. 2008. PMID: 18506687 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
